Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Text messages and letters aim to bring young cancer survivors back to the doctor

NCT ID NCT07138040

Knowledge-focused Sponsor: Children's Hospital of Philadelphia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether simple digital tools—like letters and text messages—can encourage adolescent and young adult survivors of childhood cancer to schedule and attend long-term follow-up appointments. About 530 participants who are overdue for care will receive different combinations of these nudges. The goal is to find the best way to re-engage them in monitoring for late effects of their cancer treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital behavioral interventions (written information and text messages)
What this could lead to
If successful, this could show simple digital tools help young cancer survivors get back to needed follow-up care, improving long-term health.
What could go wrong
This is a behavioral study, not a drug trial. It tests whether reminders and information work, not a cure. Results may vary by individual and setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 530 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 29 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for AYA 1. 15-29 years old 2. History of a childhood cancer diagnosis, diagnosed prior to age 22 3. Has not had a cancer-related follow-up visit in at least 15 months (or is 3 months past recommended follow-up) 4. U.S. resident (not international patient) 5. Has previously attended a cancer-related appointment at Children's Hospital of Philadelphia, or Nationwide Children's Hospital or Penn 6. At least 2 years from end of treatment and 5 years from diagnosis 7. English proficient 8. For AYA under age 18, must have a caregiver to provide informed consent Exclusion Criteria for AYA 1. Cognitive impairment limiting participation 2. Received surgery only treatment 3. Transferred to primary care 4. Currently living with cancer diagnosis (either new, metastatic, recurrence, or relapse) 5. Absence of documentation of treatment history 6. Absence of inclusion criteria above Inclusion Criteria for Support Person of AYA 1. Primary caregiver or other support person (e.g. partner, sibling, other caregiver) 2. At least 18 years old 3. U.S. resident 4. English proficient Exclusion Criteria for Support Person of AYA 1. No involvement in the AYA's healthcare 2. AYA Decline support person's participation 3. Absence of inclusion criteria above

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Nationwide Children's Hospital

    RECRUITING

    Columbus, Ohio, 43205, United States

  • Penn Medicine

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.